Last update:
Medications news
Medications
Enzalutamide helps extend life for men with advanced prostate cancer, five-year follow-up finds
The combination of enzalutamide with androgen deprivation therapy (ADT) significantly increases the chance of five-year survival for men with metastatic hormone-sensitive prostate cancer, according to a five-year follow-up ...
15 hours ago
0
2
Medications
Trend toward survival benefit seen for REM-inhibition in ALS
For patients with amyotrophic lateral sclerosis (ALS), rapid eye movement (REM) inhibition via receipt of antidepressant medication is associated with a trend toward survival benefit, according to a study presented at the ...
May 22, 2025
0
0
New combination therapy found safe and feasible for neuroendocrine tumor patients
A new combination therapy that pairs a radiopharmaceutical (177Lu-DOTATATE) with a DNA-repair blocker (olaparib) has been deemed feasible and tolerable for neuroendocrine cancer patients. The combined therapy works by preventing ...
May 22, 2025
0
0
Study questions precautionary measures on paternal use of valproate
A new study from researchers at Aarhus University and Aarhus University Hospital found no increased risk of neurodevelopmental disorders in children whose fathers were treated with valproate during spermatogenesis. The results ...
May 22, 2025
0
0
Antidepressant withdrawal symptoms more common among long-term users, study finds
People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study led by ...
May 22, 2025
0
0
Small molecules in plant-based foods may reduce efficacy of anti-cancer drugs
A Ludwig Cancer Research study has uncovered a surprising link between diet, intestinal microbes and the efficacy of cancer therapy.
May 21, 2025
0
53
Generic drugs can be reliably supplied at big savings, study finds
A new study finds that CivicaScript, a not-for-profit drug manufacturer in the US, can reliably supply essential generic medicines at a price that saves patients over 60%, and public and private insurers over 90%, demonstrating ...
May 21, 2025
0
0
Candidate drug that boosts protective brain protein in mice has potential to treat Alzheimer's disease
As researchers work to improve treatment of Alzheimer's disease, new research by UCLA Health identified a candidate drug that reduces levels of a toxic form of a protein in the brain caused by the disease and improved memory ...
May 21, 2025
0
43
Pulmonary fibrosis: Nerandomilast inhibits phosphodiesterase 4B, may treat multiple forms of disease
A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical trials. Pulmonary fibrosis is a very serious disease, with a life prognosis of 3 to 5 years after ...
May 21, 2025
0
3
Promising results of niraparib appear in patients with advanced melanoma
Researchers at Sutter's California Pacific Medical Center (CPMC) in San Francisco, Calif. have discovered early signs of clinical benefit while testing niraparib, a PARP inhibitor, in patients with advanced melanoma whose ...
May 21, 2025
0
0
Proposed algorithm to assess and de-label false penicillin allergy labels
A team of Monash University researchers have successfully piloted an algorithm to identify incorrect penicillin allergy labels and educate patients presenting to community pharmacies.
May 21, 2025
0
0
How marijuana legalization has affected traditional drug prescriptions
Approval of recreational and medical cannabis laws in most U.S. states has allowed individuals to legally obtain cannabis to treat certain medical ailments that had typically been treated with prescription drugs. New research ...
May 21, 2025
0
0
FDA approves Zynyz as first-line treatment for advanced anal cancer
The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.
May 21, 2025
0
0
Combined oral contraceptives triple risk of cryptogenic stroke in young women, new study shows
New research presented today at the European Stroke Organization Conference (ESOC 2025) held in Helsinki, May 21–23, revealed that the use of combined oral contraceptives (OCs) is associated with a threefold increase in ...
May 21, 2025
0
0
Researchers identify promising treatment for fentanyl-xylazine overdoses
Researchers at Marshall University have developed a promising treatment strategy to address overdoses involving fentanyl and the veterinary sedative xylazine, a combination increasingly linked to severe health complications ...
May 20, 2025
0
2
Study advances cancer precision therapies by identifying patients who benefit from bexmarilimab treatment
Researchers at the University of Turku, Finland, have taken a step towards more personalized and effective cancer treatments. A new study has identified the conditions under which the antibody drug bexmarilimab can activate ...
May 20, 2025
0
0
Novo Nordisk and US biotech company team up to create obesity pills
Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, type 2 diabetes and other metabolic diseases.
May 20, 2025
0
0
Pharmacists stockpile most common drugs on chance of targeted Trump tariffs
In the dim basement of a Salt Lake City pharmacy, hundreds of amber-colored plastic pill bottles sit stacked in rows, one man's defensive wall in a tariff war.
May 20, 2025
0
0
Amiloride found to be as effective as spironolactone in managing resistant hypertension
Yonsei University College of Medicine-led research has shown amiloride is as effective as spironolactone in reducing systolic blood pressure (SBP) over 12 weeks in patients with resistant hypertension.
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
Findings from a first-of-its-kind virtual trial in pulmonary medicine, conducted at Rutgers and many other institutions, suggest adding an inhaled corticosteroid to rescue therapy could sharply reduce the danger of severe ...
May 19, 2025
0
39
Drug typically used for opioid addiction could be long COVID treatment
Low-dose naltrexone (LDN) has been identified as a potential treatment for Long COVID after a Griffith University study, published in Frontiers in Molecular Biosciences, found it restored cellular function in human cells.
May 19, 2025
0
314
Study suggests dosing of heart failure medication can be safely simplified
An estimated 32 million people globally have heart failure with reduced ejection fraction, a condition where the lower left chamber of the heart does a poor job of pumping blood to the rest of the body.
May 19, 2025
0
0
Allopurinol designated as the first orphan drug for Marfan syndrome treatment
The European Medicines Agency (EMA) has designated allopurinol as the first orphan drug for the treatment of Marfan syndrome, a rare connective tissue disease which has no cure to date. This disease causes an aortic aneurysm ...
May 19, 2025
0
7
Methotrexate as effective as prednisone in pulmonary sarcoidosis, research finds
Prednisone is recommended as the first-line treatment for pulmonary sarcoidosis, but this steroid causes a number of unwanted side effects. Now new research, published at the ATS 2025 International Conference and in the American ...
May 18, 2025
0
0
New discovery about how acetaminophen works could improve understanding about pain relievers
A new study from Indiana University scientists may aid the pharmaceutical industry in better understanding a popular over-the-counter pain reliever: Tylenol.
May 16, 2025
0
61
